Table 1.
Description of the adapted version of the WHO-Composite International Diagnostic Interview (WHO-CIDI) used in the PEGASUS-Murcia project
| Sections | Module | Number of items | Rules for administration* |
|---|---|---|---|
| Household listing | Methodological | 5 | All respondents |
| screening (SCR) | Screening | 51 | All respondents |
| Minimental state examination | Risk factors | If older than 60 years old | |
| Quality/lie subscale‡ | Functioning and physical disorder | 24 | Random assignment to the beginning of the questionnaire or at the end |
| Depression | Mood disorder | 189 | Screening questions (SCR) |
| Mania | Mood disorder | 95 | Screening questions (SCR) |
| Panic disorder | Anxiety | 106 | Screening questions (SCR) |
| Specific phobia | Anxiety | 143 | Screening questions (SCR) |
| Social phobia | Anxiety | 85 | Screening questions (SCR) |
| Agoraphobia | Anxiety | 84 | Screening questions (SCR) |
| General anxiety disorder | Anxiety | 116 | Screening questions (SCR) |
| Suicidality | Other diagnostic | 46 | All respondents |
| Use of services | Treatment | 243 | All respondents |
| Group of questions (tobacco and physical exercise) | Risk/protective factors | 22–32 | All respondents |
| Pharmacoepidemiology | Treatment | 241 | All respondents |
| Substances | Substance abuse | 182 | Long path |
| Post-traumatic stress disorder | Anxiety | 464–491 | Long path |
| Chronic conditions | Functioning and physical disorder | 201 | Long path |
| 30 days functions | Functioning and physical disorder | 75 | Long path |
| 30 days symptoms | Functioning and physical disorder | 75 | Long path |
| Eating disorders | Other diagnostic | 80 | 50% of long path |
| Obsessive-compulsive disorder | Anxiety | 124 | 33% of long path |
| CAPE | Psychosis | 42–84 | All respondents |
| CFQ | Risk factors | 25 | All respondents |
| SLE | Risk factors | 13–39 | All respondents |
| Neuroticism and extroversion subscales† | Risk/protective factors | 12 | All respondents |
| Resilience scale | Protective factors | 25 | All respondents |
| Employment | Sociodemographics | 121 | Long path |
| finances | Sociodemographics | 21 | Long path |
| Marriage | Sociodemographics | 91 | All respondents |
| Partner violence | Risk factors | 2–15 | All respondents |
| Children | Sociodemographics | 44 | Long path |
| Social networks | Risk/protective factors | 16 | All respondents |
| Adult demographics | Sociodemographics | 68 | Long path |
| Child demographics | Sociodemographics | 34 | Long path |
| Demographic short | Sociodemographics | 25–36 | Long path |
| Childhood | Risk/protective factors | 110 | Long path |
| Attention hyperactivity | Childhood | 90 | Long path and screening |
| Oppositional defiant | Childhood | 46 | Long path and screening |
| Conduct disorder | Childhood | 54 | Long path |
| Separation anxiety disorder | Childhood | 86 | Screening questions (SCR) |
| Family burden | Risk factors | 40 | Long path |
| Quality/lie subscale‡ | Functioning and physical disorder | 26 | Random assignment to the beginning of the questionnaire or at the end |
| Respondent contacts | Methodological | 19 | All respondents |
| Interviewer observation | Methodological | 14 | All respondents |
*Long path inclusion criteria: (1) all individuals who could be considered as ‘high-risk individuals’, because they had positively answered a number of specific questions related to mood and anxiety disorders, and (b) a random subsample (25%) of the respondents without symptoms (‘low-risk individuals’). The remaining 75% of respondents without screening symptoms not randomly selected for the long path followed the short path of the questionnaire.
†Neuroticism and extroversion subscales of the abbreviate version of the Eysenck Personality Questionnaire (EPQR-A).
‡Lie subscale of the abbreviated version of the EPQR-A; PEGASUS-Murcia, Psychiatric Enquiry to General Population in Southeast Spain-Murcia.
CAPE, Community Assessment of Psychic Experiences; CFQ, Cognitive Failure Questionnaire; EQ-5D, European Quality of Life Scale; SF-12 v2, Short Form 12 Health Questionnaire; SLE, Stressful Life Events.